The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTPG.L Regulatory News (TPG)

  • There is currently no data for TPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Nanotechnology licence agreement

3 Jun 2019 07:00

RNS Number : 8270A
TP Group PLC
03 June 2019
 

RNS Reach

3 June 2019

 

TP Group plc

("TP Group" or the "Company" or the "Group")

 

Nanotechnology licence for carbon dioxide treatment

TP Group (AIM: TPG), the specialist services and engineering group, has entered into a nine year exclusive licensing agreement with Batelle Inc., to be a technology partner for their innovative nanotechnology material, SAMMS (the "Agreement"). The Agreement enables TP Group to develop and deploy carbon dioxide (CO2) removal equipment for transportation and life support systems in ground, marine, air and space vehicles.

Batelle Inc. is a global research and development organisation, headquartered in Columbus, Ohio in the United States. Their facility at Pacific Northwest National Laboratory has produced a new nanostructured sorbent material. SAMMS was originally developed under funding from the US Department of Energy to bind mercury from contaminated groundwater. It has many other applications including the treatment of carbon dioxide.

It is intended that the SAMMS material will be used as the basis for an alternative approach to management of carbon dioxide levels in confined spaces. The new systems are designed to offer a technological and performance boost in this application as the sand-like material differs from existing treatments in either solid or liquid form and eliminates certain of their environmental and operational issues.

TP Group will continue to work with the traditional systems that it has supplied to many global customers, with the new systems sitting alongside these to provide a more comprehensive range of options in this field.

Phil Cartmell, Chief Executive Officer of TP Group, commented:

"This Agreement demonstrates our continued and successful investment in technology development and adoption to deliver the most advanced solutions to our customers whilst also allowing them to select from a range of options to find the one that best suits their long-term operational needs.

"It is part of TP Group's strategy to develop a Centre of Excellence for gas and fluid management systems - specifically arising from our historical strength in CO2 capture. This Agreement complements our partnership with Micropore Inc. and contributes to the Group's plan to be a trusted provider of a range of compact, high-performance equipment with many applications in the defence, space and global energy sectors."

 

For further information, please contact:

 

TP Group plc

Tel: 01753 285 810

Phil Cartmell, Chief Executive Officer

Derren Stroud, Chief Financial Officer

www.tpgroup.uk.com

Cenkos Securities plc

Tel: 020 7397 8980

Mark Connelly / Stephen Keys / Callum Davidson

www.cenkos.com

Vigo Communications

Tel: 020 7390 0230

Jeremy Garcia / Fiona Henson / Charlie Neish

www.vigocomms.com

 

 

Notes to Editors

 

TP Group designs and develops advanced technologies, engineers complex equipment and systems, and provides support throughout their operational life. The Company's shares have been traded on AIM since July 2001.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRALLFEEEDILVIA
Date   Source Headline
28th Apr 20085:40 pmRNSResult of AGM
9th Apr 20082:33 pmRNSHolding(s) in Company
3rd Apr 200812:30 pmRNSIssue of Equity
26th Mar 20087:01 amRNSDirectorate Changes
5th Mar 20082:11 pmRNSHolding(s) in Company
5th Mar 200810:32 amRNSIssue of Equity
22nd Feb 200811:15 amRNSIssue of Equity
21st Feb 20082:51 pmRNSHolding(s) in Company
19th Feb 20087:00 amRNSPreliminary Results
21st Jan 20084:09 pmRNSNotice of Results
28th Dec 20072:48 pmRNSDirector/PDMR Shareholding
12th Dec 200710:06 amRNSIssue of Equity
11th Dec 20073:33 pmRNSHolding(s) in Company
15th Nov 20074:34 pmRNSIssue of Equity
7th Nov 200712:11 pmRNSDirector/PDMR Shareholding
6th Nov 200711:19 amRNSIssue of Equity
30th Oct 200712:00 pmRNSHolding(s) in Company
26th Oct 20071:42 pmRNSHolding(s) in Company
23rd Oct 20079:48 amRNSHolding(s) in Company
18th Oct 20077:01 amRNSDGC Flow Loop Update
1st Oct 20075:07 pmRNSHolding(s) in Company
21st Sep 20077:01 amRNSInterim Results
14th Sep 20077:00 amRNSChange of Adviser
17th Aug 20076:04 pmRNSAIM Rule 26
10th Jul 20073:56 pmRNSNotice of Results
20th Jun 20076:25 pmRNSHolding(s) in Company
20th Jun 20076:22 pmRNSHolding(s) in Company
24th Apr 20075:09 pmRNSAGM Statement
12th Apr 20079:36 amRNSDirector/PDMR Shareholding
9th Mar 20079:17 amRNSNew Order Win
9th Mar 20077:01 amRNSPreliminary Results
1st Feb 20077:01 amRNSGas Seals Agreement
8th Jan 200712:34 pmRNSExercise of Options
8th Jan 200712:23 pmRNSNotice of Results
2nd Jan 20077:01 amRNSContract Win
21st Dec 20064:45 pmRNSBoard Change
20th Dec 200611:37 amRNSVoting Rights and Capital
7th Dec 20063:45 pmRNSR&D Tax Credits
19th Sep 20067:01 amRNSDTI Grant and First Shipment
19th Sep 20067:01 amRNSInterim Results
7th Sep 20067:03 amRNSContract with Advantica
25th Aug 20068:49 amRNSNotice of Results
9th May 200610:47 amRNSHolding(s) in Company
2nd May 20065:19 pmRNSResult of AGM
27th Apr 200610:00 amRNSIssue of Equity
24th Apr 200610:04 amRNSDirectorate Change
11th Apr 20067:00 amRNSGrant of Options
3rd Apr 20067:01 amRNSDirectorate Change
29th Mar 20067:02 amRNSFinal Results
6th Mar 200610:27 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.